Transfusion of pathogen‐reduced platelet components without leukoreduction

BACKGROUND: Leukoreduction (LR) of platelet concentrate (PC) has evolved as the standard to mitigate risks of alloimmunization, clinical refractoriness, acute transfusion reactions (ATRs), and cytomegalovirus infection, but does not prevent transfusion‐associated graft‐versus‐host disease (TA‐GVHD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Joycelyn, Tsoi, Wai Chiu, Lee, Cheuk Kwong, Leung, Rock, Lam, Clarence C. K., Koontz, Claudia, Liu, Amy Yingjie, Huang, Norman, Benjamin, Richard J, Vermeij, Hans J., Stassinopoulos, Adonis, Corash, Laurence, Lie, Albert K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Transfusion Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850058/
https://www.ncbi.nlm.nih.gov/pubmed/30919465
http://dx.doi.org/10.1111/trf.15269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850058/
https://www.ncbi.nlm.nih.gov/pubmed/30919465
http://dx.doi.org/10.1111/trf.15269

Ejemplares similares